High-resolution NMR for metabomics

Current Opinion in Drug Discovery and Development

Volumn 8, Issue 1, 2005, Pages 127-133

  Pelczer, István ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

Biomarkers; Disease diagnostics; HR MAS; Metabolomics; Metabomics; Metabonomics; Multivariate analysis; NMR; Pattern recognition; Toxicology

Indexed keywords

BIOLOGICAL MARKER;

ANALYTIC METHOD; DIAGNOSTIC TEST; DRUG DETERMINATION; MASS SPECTROMETRY; METABOLOMICS; METABONOMICS; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT;

ANIMALS; DATA INTERPRETATION, STATISTICAL; GENOMICS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PHARMACEUTICAL PREPARATIONS;

EID: 12244269071     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Pellechia M, Sem DS, Wüthrich K: NMR in drug discovery. Nature Rev Drug Disc (2002) 1:211-219.
2. Diercks T, Coles M, Kessler H: Applications of NMR in drug discovery. Curr Opin Chem Biol (2001) 5(3):285-291.
3. Liu B, Li S, Hu J: Technological advances in high-throughput screening. Am J Pharmacogenomics (2004) 4(4):263-276.
4. Freeman R: Magnetic Resonance in Chemistry and Medicine. Oxford University Press, New York, NY, USA (2003). An outstanding handbook on NMR spectroscopy and applications, highly recommended for both novice and more experienced NMR users.
5. Pelczer I: Structural biology, ligand binding, metabomics - the changing face of high-field, high-resolution NMR spectroscopy. J Mol Struct (Theochem) (2003) 666:499-505.
6. Griffin JL: Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterization of xenobiotic toxicity and disease diagnosis. Curr Opin Chem Biol (2003) 7(5):648-654.
7. Lindon JC, Holmes E, Nicholson JK: Toxicological applications of magnetic resonance. Prog NMR Spectros (2004) 45:109-143. A comprehensive review of concepts, methods and applications for toxicology studies, including in vivo approaches.
8. Wilson ID, Nicholson JK: Solid-phase extraction chromatography and nuclear magnetic resonance spectrometry for the identification and isolation of drug metabolites in urine. Anal Chem (1987) 59(23):2830-2832.
9. Nicholson JK, Holmes E, Lindon JC, Wislon ID: The challenges of modeling mammalian biocomplexity. Nat Biotechnol (2004) 22(10):1268-1274. Conceptual summary of the hierarchical complexity of living systems and the ways in which they can be analyzed. Compares timescales of 'omics' events, and recommends integrated use of these methods.
10. Tang H, Wang Y, Nicholson JK, Lindon JC: Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal Biochem (2004) 325(2):260-272. A good example of the combined use of 1D and 2D NMR methods, a variety of experimental filtering techniques, and detailed component analysis.
11. 13C NMR spectroscopy of urine for metabonomic studies. Anal Chem (2002) 74(17):4588-4593.
12. 13C HMBC-NMR spectroscopy combined with pattern recognition procedures performed on filtered variables. Anal Chem (2002) 74(10):2261-2273.
13. Willis RC, Filmore D: Devil in the details. No matter what you call it, metabolic profiling is crucial to drug discovery and health. Mod Drug Disc (2004) 7(8):34-38. A good report on current conflicting views, highlighting the importance of metabolic studies in drug research.
14. Nicholson JK, Connelly J, Lindon JC, Holmes E: Metabonomics: A platform for studying drug toxicity and gene function. Nat Rev Drug Disc (2002) 1(2):153-161. The 'classic' review on metabonomics.
15. Nicholson JK, Wilson ID: Understanding 'global' systems biology: Metabonomics and the continuum of metabolism. Nat Rev Drug Disc (2003) 2(8):668-676. This review discusses the concepts of 'global' understanding and the assessment of biology at the system level in its real complexity, including the probabilistic nature of metabolic processes.
16. Connelly J: Metabonomics: Of mice, man and sacred cows. Metabolic Profiling: Application to Toxicology and Risk Reduction, Research Triangle Park, NC, USA (2003).
17. Sauer U: High-throughput phenomics: Experimental methods for mapping fluxomes. Curr Opin Biotechnol (2004) 15(1):58-63.
18. Kuiper HA, Kok EJ, Engel K-H: Exploitation of molecular profiling techniques for GM food safety assessment. Curr Opin Biotechnol (2003) 14(2):238-243.
19. 1H NMR spectroscopy as a tool to detect potential unintended effects following a genetic modification. J Agric Food Chem (2003) 51 (9):2447-2456.
20. Viant MR, Rosenblum ES, Tjeerdema RS: NMR-based metabolomics: A powerful approach for characterizing the effects of environmental Stressors on organism health. Environ Sci Technol (2003) 37(21):4982-4989. A pioneering example of how metabomics can be used to monitor possibly low-level environmental changes indirectly through well-selected species of the local fauna or flora.
21. 1H NMR spectroscopy and chemometrics. Phytochemistry (2003) 62(6):851-858.
22. Polkowska Ż, Koztowska K, Namiesnik J, Przyjazny A: Biological fluids as a source of information on the exposure of man to environmental chemical agents. Crit Rev Anal Chem (2004) 34(2):105-119.
23. Sumner LW, Mendes P, Dixon RA: Plant metabolomics: Large-scale Phytochemistry in the functional genomics era. Phytochemistry (2003) 62(6):817-836.
24. Bligny R, Douce R: NMR and plant metabolism. Curr Opin Plant Biol (2001) 4(3)191-196.
25. Fan TW, Lane AN, Shenker M, Bartley JP, Crowley D, Higashi RM: Comprehensive chemical profiling of gramineous plant root extrudes using high-resolution NMR and MS. Phytochemistry (2001) 57(2):209-221.
26. 13C NMR spectroscopic analysis of human saliva. J Dent Res (2002) 81(6):422-427.
27. Pelczer I, Case MA, Fields AP, Gadiraju S, Gerchman Y, Subramanian S, Kalmbach AS, Soroka TA, Tang Y, Wang JM, Wist AD et al: Cells, cell-extracts and alternative biofluids for NMR-based metabomics. 7th Annual Symposium on Chemical and Pharmaceutical Structure Analysis (CPSA), Princeton, NJ, USA (2004).
28. Hinse C, Richter C, Provenzani A, Stöckigt J: In vivo monitoring of alkaloid metabolism in hybrid plant cell cultures by 2D cryo-NMR without labelling. Bioorg Med Chem (2003) 11(18):3913-3919.
29. Griffin JL, Shockcor JP: Metabolic profiles of cancer cells. Nat Rev Cancer (2004) 4(7):551-561. An outstanding review, which focuses on cell-level analysis using cell-cultures and extracted tissues; gives a comprehensive overview of available analytical methods for such studies, and promotes their integrated use for diagnosis and drug research.
30. Huhn SD, Szabo CM, Gass JH, Manzi AE: Metabolic profiling of normal and hypertensive rat kidney tissues by HRMAS-NMR spectroscopy. Anal Bioanal Chem (2004) 378(6):1511-1519.
31. Pelczer I: NMR analysis of living cells and their extracted metabolome: A prototype for cell-based toxicology? Metabolic Profiling: Pathways in Discovery, Lake Buena Vista, FL, USA (2004).
32. Lindon JC, Holmes E, Nicholson JK: Pattern recognition methods and applications in biomedical magnetic resonance. Prog NMR Spectros (2001)39:1-40. Provides a comprehensive introduction to, and summary of the most widely used data analysis methods, including real-life examples.
33. Aranlbar N, Singh BK, Stockton GW, Ott K-H: Automated mode-of-action detection by metabolic profiling. Biochem Biophys Res Commun (2001) 286(1):150-155.
34. Stoyanova R, Nicholson JK, Lindon JC, Brown TR: Sample classification based on Bayesian spectral decomposition of metabonomic NMR data sets. Anal Chem (2004) 76(13):3666-3674.
35. Ebbels T, Keun H, Beckonert O, Antti H, Bollard M, Holmes E, Lindon J, Nicholson J: Toxicity classification from metabonomics data using a density superposition approach: 'CLOUDS'. Anal Chim Acta (2003) 490:109-122.
36. Eads CD, Furnish CM, Noda I, Juhlin KD, Cooper DA, Morrall SW: Molecular factor analysis applied to collections of NMR spectra. Anal Chem (2004) 76(7):1982-1990.
37. 1H NMR spectroscopic metabonomic studies. Anal Chem (2004): in press.
38. Keun HC, Ebbels, TM, Bollard ME, Beckonert O, Antti H, Holmes E, Lindon JC, Nicholson JK: Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles. Chem Res Toxicol (2004) 17(5):579-587. Trajectory analysis is an essential tool in metabomics, which carries outstanding diagnostic value in a wide range of applications.
39. 1H-NMR datasets. Anal Chem (2005): in press. This new approach may open a new chapter in the analysis of large metabolic datasets; it can lead to direct and potentially automated identification of biomarkers and their correlated behavior, including their structure identification.
40. Elyashberg ME, Blinov KA, Williams AJ, Martirosian ER, Molodtsov AG: Application of a new expert system for the structure elucidation of natural products from their 1D and 2D NMR data. J Nat Prod (2002) 65(5):693-703. For more information about sophisticated spectrum analysis, integration of information obtained from various analytical methods, and capabilities of recent prediction tools see www.acdlabs.com.
41. Lindon JC, Nicholson JK, Holmes E, Antti H, Bollard ME, Keun H, Beckonert O, Ebbels TM, Reily MD, Robertson D, Stevens GJ et al: Contemporary issues in toxicology. The role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol Appl Pharm (2003) 187(3):137-146. A project of historic proportions with regard to metabolic studies.
42. Nicholls AW, Mortishire-Smith RJ, Nicholson J: NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem Res Toxicol (2003) 16(11):1395-1404.
43. 1H NMR spectra. Phytochemistry (2003) 62(6):1009-1017.
44. Stoyanova R, Nicholls AW, Nicholson JK, Lindon JC, Brown TR: Automatic alignment of individual peaks in large high-resolution spectral data sets. J Magn Resonance (2004) 170(2):329-335.
45. 1H-NMR-based metabonomics. Nat Med (2002) 8(12):1439-1444. A sensational pioneering example of direct application to medical diagnostics using simple and inexpensive, yet fully reliable NMR-based methods, which proves to be competitive compared to the most efficient conventional medical diagnosis.
46. Espina JR, Shockcor JP, Herron WJ, Car BD, Contel NR, Ciaccio PJ, Lindon JC, Holmes E, Nicholson JK: Detection of in vivo biomarkers of phospholipidosis using NMR-based metabonomic approaches. Magn Reson Chem (2001) 39:559-565. An encouraging example of extremely early diagnosis of a serious disease using metabolic analysis and an identified biomarker. Such a clear success story is unlikely to happen often, but it certainly demonstrates the power of metabolite/biomarker identification.
47. Engelke UF, Liebrand-van Sambeek LF, de Jong JG, Leroy JG, Morava E, Smelting JA, Wevers RA: N-acetylated metabolites in urine: Proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism. Clin Chem (2004) 50(1):58-66.
48. Wang Y, Holmes E, Nicholson JK, Cloarec O, Chollet J, Tanner M, Singer BH, Utzinger J: Metabonomic investigations in mice infected with Schistosoma mansoni: An approach for biomarker identification. Proc Natl Acad Sci USA (2004) 101(34):12676-12681. The importance of this paper should not be undervalued. The area of tropical diseases, specifically diagnosis and treatment of (multiple) parasitic infection is highly neglected and there are limited tools for such diagnosis. Metabolic analysis shows great promise, as illustrated by this pioneering work.